[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337917-105":59,"doc-detail-337917-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","current-evidence-supporting-associations-of-dna-methylation-measurements-with-survivorship-burdens-in-cancer-survivors-a-scoping-review","Current evidence supporting associations of DNA methylation measurements with survivorship burdens in cancer survivors - A scoping review","","A scoping review synthesizes current studies linking peripheral blood DNA methylation (DNAm) to survivorship burdens among cancer survivors. Reliable biomarkers for persistent symptoms remain challenging, and epigenetic changes from anti-cancer therapy may offer actionable biological insights. The review identifies 22 studies, assessing associations using epigenetic age metrics, individual CpG sites, or genomic regions while accounting for confounders, with findings supporting DNAm as a potential biomarker for survivorship care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/current-evidence-supporting-associations-of-dna-methylation-measurements-with-survivorship-burdens-in-cancer-survivors-a-scoping-review/337917/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/current-evidence-supporting-associations-of-dna-methylation-measurements-with-survivorship-burdens-in-cancer-survivors-a-scoping-review/337917.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the review’s main objective?","Question",{"text":112,"@type":113},"To provide an overview of current studies examining associations between DNA methylation (DNAm) and survivorship burdens in cancer survivors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which studies were included in the scoping review?",{"text":117,"@type":113},"Studies were included if they focused on cohorts of cancer survivors, used peripheral blood cell DNAm data, and evaluated associations between DNAm and survivorship-related issues.",{"name":119,"@type":110,"acceptedAnswer":120},"What kinds of survivorship outcomes and DNAm measurements were examined?",{"text":121,"@type":113},"The review assessed outcomes spanning neurocognition, psychiatric health, general wellness, chronic conditions, and treatment-specific toxicities, using epigenetic age metrics and DNAm levels at individual CpG sites or regions while considering confounding factors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337917,1790430161,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","DOI: 10. 1002/cam4 .7470  \nREVIEW  \nCurrent evidence supporting associations of DNA methylation measurements with survivorship burdens in cancer survivors: A scoping review  \nMichael Sayer1  | Ding Quan Ng1 | Raymond Chan2 | Kord Kober3  | Alexandre Chan1   \n1School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, Irvine, California, USA  \n2School of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia  \n3School of Nursing, University of California San Francisco, San Francisco, California, USA  \nCorrespondence  \nAlexandre Chan, University of California, Irvine, 802 W Peltason Dr, Berk Hall, Irvine, CA 92697-4625, USA. [Email:](Email: a.chan@uci.edu)[ a.chan@uci.edu](Email: a.chan@uci.edu)  \nAbstract  \nIntroduction: Identifying reliable biomarkers that reflect cancer survivorship symptoms remains a challenge for researchers. DNA methylation (DNAm) measurements reflecting epigenetic changes caused by anti-cancer therapy may provide needed insights. Given lack of consensus describing utilization of DNAm data to predict survivorship issues, a review evaluating the current landscape is warranted.  \nObjective: Provide an overview of current studies examining associations of DNAm with survivorship burdens in cancer survivors.  \nMethods: A literature review was conducted including studies if they focused on cohorts of cancer survivors, utilized peripheral blood cell DNAm data, and evaluated the associations of DNAm and survivorship issues.  \nResults: A total of 22 studies were identified, with majority focused on breast (n = 7) or childhood cancer (n = 9) survivors, and half studies included less than 100 patients (n = 11). Survivorship issues evaluated included those related to neurocognition (n = 5), psychiatric health (n = 3), general wellness (n = 9), chronic conditions (n = 5), and treatment specific toxicities (n = 4) . Studies evaluated epigenetic age metrics (n = 10) and DNAm levels at individual CpG sites or regions (n = 12) for their associations with survivorship issues in cancer survivors along with relevant confounding factors. Significant associations of measured DNAmin the peripheral blood samples of cancer survivors and survivorship issues were identified.  \nDiscussion/Conclusion: Studies utilizing epigenetic age metrics and differential methylation analysis demonstrated significant associations of DNAm measurements with survivorship burdens. Associations were observed encompassing diverse survivorship outcomes and timeframes relative to anti-cancer therapy initiation. These findings underscore the potential of these measurements as useful biomarkers in survivorship care and research.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e7470 .  \n[https://doi.org/10.1002/cam4.7470](https://doi.org/10.1002/cam4.7470)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 15  \nKEYWORDS  \ncancer survivorship, differential DNA methylation, epigenetic aging, epigenetics, literature review, multivariate modeling, study design  \n1 | INTRODUCTION  \nWhile significant advances have improved cancer treatment, patients still cope with persistent survivorship issues. In studies comparing health status of cancer survivors and healthy counterparts, survivors were many times more likely to experience chronic and severe illnesses.1,2 Examples range from impaired cognition, increased anxiety and depression, excessive fatigue, and an increased likelihood of developing cardiovascular comorbidities.3–6 These issues likely contribute to a reduced quality of life for cancer survivors, even years removed from active treatment.7–10  \nThere are many speculated reasons for these persistent issues in cancer sur","cbCaimen8tTLBkEn","https://ap.wps.com/l/cbCaimen8tTLBkEn","pdf",1977040,15,"English","# Introduction\n## DNA methylation as a survivorship biomarker\n# Methods\n## Literature review inclusion criteria\n# Results\n## Study characteristics and outcomes\n# Discussion/Conclusion\n## Implications for survivorship care","[{\"question\":\"What is the review’s main objective?\",\"answer\":\"To provide an overview of current studies examining associations between DNA methylation (DNAm) and survivorship burdens in cancer survivors.\"},{\"question\":\"Which studies were included in the scoping review?\",\"answer\":\"Studies were included if they focused on cohorts of cancer survivors, used peripheral blood cell DNAm data, and evaluated associations between DNAm and survivorship-related issues.\"},{\"question\":\"What kinds of survivorship outcomes and DNAm measurements were examined?\",\"answer\":\"The review assessed outcomes spanning neurocognition, psychiatric health, general wellness, chronic conditions, and treatment-specific toxicities, using epigenetic age metrics and DNAm levels at individual CpG sites or regions while considering confounding factors.\"}]","Current evidence supporting associations of DNA methylation measurements with survivorship burdens in cancer survivors - A scoping review | PDF",1790021171,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46de02e986b6b11b69e75b9f74581aed.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d67c37821e128b07403f4607455ec2c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11de25be19a07508bea8f50388a7977a.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f44c301ae6059a80f759ba746ee4c361.webp",980,1287]